General Manager, Immunoscore and International Diagnostics Operations
Stephane Debono is an entrepreneur who brings more than 25 years of executive experience in life sciences and health care to Veracyte. He most recently served as Deputy Chief Executive Officer of HalioDx, an immuno-oncology diagnostics company, and Chief Executive Officer of its U.S. subsidiary, HalioDx, Inc., and also led HalioDx’s Executive Committee to manage the company’s growth. Mr. Debono cofounded Ipsogen in 1999 and successfully developed and managed the company’s operations, including services and product manufacturing, as well as the company’s finances and shareholder reporting. Following Ipsogen’s acquisition by Qiagen, Mr. Debono oversaw European molecular diagnostics manufacturing operations for Qiagen’s IVD products in cancer and infectious diseases. Mr. Debono holds an Engineering degree from Ecole Centrale de Marseille and a Master’s degree in Finance from Euromed Marseille.